Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.
Alphyn Biologics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Alphyn Biologics's investors include Queen City Angels, Angel Physicians Fund, Serial Stage Venture Partners.
Alphyn Biologics is headquartered in Cincinnati, United States.
Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.
Alphyn Biologics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alphyn Biologics — Funding & Investors." VCBacked, December 12, 2025, https://www.vcbacked.co/company/alphyn-biologics. Accessed August 1, 2026.
VCBacked. (2025). Alphyn Biologics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/alphyn-biologics
{{cite web |title=Alphyn Biologics — Funding & Investors |url=https://www.vcbacked.co/company/alphyn-biologics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated